Bruker Corp (NAS:BRKR)
$ 75.07 -0.75 (-0.99%) Market Cap: 10.91 Bil Enterprise Value: 12.03 Bil PE Ratio: 27.30 PB Ratio: 7.71 GF Score: 96/100

Bruker Corp at JPMorgan Healthcare Conference Transcript

Jan 08, 2024 / 04:15PM GMT
Release Date Price: $72.54 (+4.48%)
Rachel Marie Vatnsdal Olson
JPMorgan Chase & Co, Research Division - Analyst

Perfect. Good morning, everyone. This is Rachel Vatnsdal from the life science tools and diagnostics team at JPMorgan. Pleased to introduce Bruker. Frank Laukien is going to do the presentation. As we typically do for these, it will be 20, 25 minutes of a presentation followed by Q&A. If any of you in the room have questions, feel free to either submit them via the app on the Meta meeting's website or ping me directly. With that, Frank, why don't you take it away?

Frank H. Laukien
Bruker Corporation - Chairman, CEO & President

Good morning, and thank you, everybody, for being here. I want to acknowledge 2 of our directors, very pleased that you could make it. Thank you. Thank you, Rachel, for having us and giving us this excellent time slot, while we're all awake and psyched for this conference. I'd like to acknowledge 2 of my colleagues, our CFO, Gerald Herman; and Mark Munch, who runs our Bruker Nano group and there's a lot of the spatial biology field and single cell

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot